Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

67 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Sale
447,778$34.22$15.3M605,771(D)

View →

Feb 17, 2026Feb 18 11:28 AMFrancis Richard D
Proposed Sale
447,778$34.22$15.3M

View →

Feb 17, 2026Feb 18 11:12 AMFrancis Richard D
Proposed Sale
447,778$1.00$447.8K

View →

Dec 12, 2025Dec 12 9:17 PMBridger Management, LLC (1)
Proposed Sale
150,000$30.18$4.5M

View →

Dec 9, 2025Dec 9 9:03 PMSabag Mark
Proposed Sale
216,892$28.73$6.2M

View →

Dec 9, 2025Dec 9 9:00 PMDaniell Richard
Proposed Sale
115,468$28.68$3.3M

View →

Nov 26, 2025Nov 26 9:02 PMBridger Management, LLC (1)
Proposed Sale
50,000$24.99$1.2M

View →

Nov 20, 2025Nov 20 9:19 PMFox Christine
Proposed Sale
28,229$24.78$699.5K

View →

Nov 14, 2025Nov 14 8:59 PMFox Christine
Proposed Sale
30,000$25.11$753.3K

View →

Nov 6, 2025Nov 7 12:46 AMBridger Management, LLC (1)
Proposed Sale
200,000$24.60$4.9M

View →

Sep 12, 2025Sep 12 8:05 PMBridger Management, LLC (1)
Proposed Sale
95,000$19.89$1.9M

View →

Aug 1, 2025Aug 1 8:04 PMJover Placid
Proposed Sale
6,053$15.16$91.7K

View →

Aug 1, 2025Aug 1 8:01 PMHughes Eric A
Proposed Sale
52,742$15.16$799.4K

View →

Jun 12, 2025Jun 12 8:18 PMKalif Eliyahu Sharon
Proposed Sale
55,775$17.08$952.5K

View →

Jun 3, 2025Jun 3 7:59 PMShields Matthew
Proposed Sale
6,206$17.02$105.6K

View →

May 8, 2025May 8 6:34 PMSabag Mark
Proposed Sale
337,915$18.04$6.1M

View →

Mar 5, 2025Mar 5 9:29 PMDaniell Richard
Proposed Sale
70,961$15.83$1.1M

View →

Mar 4, 2025Mar 5 12:14 AMMcAvoy David R.
Proposed Sale
4,827$16.00$77.2K

View →

Mar 4, 2025Mar 5 12:02 AMFox Christine
Proposed Sale
6,181$16.00$98.9K

View →

Mar 4, 2025Mar 4 11:57 PMMcAvoy David R.
Proposed Sale
4,827$16.00$77.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 6 9:13 PMMark SabagSee "Remarks"
Option Exercise
52,11337,202(D)

View →

Mar 4, 2026Mar 6 9:11 PMEvan LippmanEVP, Business Development
Grant/Award
27,34727,347(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Option Exercise
23,25146,503(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
56,76346,503(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Grant/Award
53,17553,175(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Option Exercise
20,46140,923(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Option Exercise
8,5107,534(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Option Exercise
16,32911,300(D)

View →

Mar 3, 2026Mar 5 9:11 PMAmir WeissChief Accounting Officer
Option Exercise
5,1795,180(D)

View →

Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Option Exercise
203,7280(D)

View →

Mar 3, 2026Mar 5 9:08 PMMark SabagSee "Remarks"
Option Exercise
166,3780(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Option Exercise
3,4613,461(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Option Exercise
958,5460(D)

View →

Mar 3, 2026Mar 5 9:03 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
191,2780(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Option Exercise
166,3780(D)

View →

Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Option Exercise
781,7660(D)

View →